SEC Form 4 · accession 0001179110-15-004046

ABBOTT LABORATORIES · ABT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Executive Vice President

Period of report

Feb 27, 2015

Accepted (ET)

Mar 3, 2015 · 5:17 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000001800

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common shares without par value	Feb 27, 2015	F	22,797	$47.61	D	347,252	D
Common shares without par value^F1	holding	—	—		—	1,098	I	Profit Sharing Trust
Common shares without par value^F2	holding	—	—		—	4,000	I	Annette Newton-Freyman 1994 Trust
Common shares without par value^F3	holding	—	—		—	76,000	I	Annette Newton-Freyman 2012 Irrevocable Trust
Common shares without par value^F4	holding	—	—		—	76,000	I	Thomas C. Freyman 2012 Irrevocable Trust
Common shares without par value^F5	holding	—	—		—	1,941	I	By spouse as trustee for son
Common shares without par value^F5	holding	—	—		—	1,941	I	By spouse as trustee for son

No Table II lines on this filing.

F1Balance in the Abbott Laboratories Stock Retirement Trust as of February 27, 2015.
F2Held in the Annette Newton-Freyman 1994 Trust. The reporting person's spouse is trustee of the trust. The trust is revocable by his spouse. The reporting person disclaims beneficial ownership of these securities.
F3Held in the Annette Newton-Freyman 2012 Irrevocable Trust. The reporting person is trustee of the trust. The trust is irrevocable. The reporting person disclaims beneficial ownership of these securities.
F4Held in the Thomas C. Freyman 2012 Irrevocable Trust. The reporting person's spouse is trustee of the trust. The trust is irrevocable.
F5The reporting person disclaims beneficial ownership of all securities held by his son.